Thursday, October 15, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 25, 2026

AMD and Nutanix Announce Strategic Partnership to Advance an Open and Scalable Platform for Enterprise AI

View original at globenewswire.com
AMD and Nutanix Announce Strategic Partnership to Advance an Open and Scalable Platform for Enterprise AI News Highlights AMD and Nutanix sign multi-year agreement to accelerate adoption of Nutanix-powered agentic AI platform on AMD accelerated compute infrastructure for enterprise AI and service providers AMD to inves…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • AMD technology powers billions of experiences across cloud and AI infrastructure, embedded systems, AI PCs and gaming

    80% confidence

  • Enterprise AI infrastructure is entering a phase where inference workloads dominate and openness is essential for long-term innovation

    80% confidence

  • Through partnership with Nutanix, AMD is building a scalable, full-stack AI platform rooted in openness, designed to give enterprises and service providers flexibility to innovate, extend and grow AI deployments

    80% confidence

  • Enterprise customers need the freedom to run the models and workloads that matter most to their business, without compromise

    80% confidence

  • First jointly-developed agentic AI platform expected to come to market beginning in late 2026

    80% confidence

  • AMD is committed to advancing an AI ecosystem built on open standards, interoperable software frameworks and architectural choice

    80% confidence

  • Partnership with AMD reflects a shared vision for scalable, production-ready AI infrastructure

    80% confidence

  • Together, AMD and Nutanix are delivering full-stack, integrated platforms optimized for inference and agentic applications across hybrid environments for enterprises and service providers

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com